Drug Profile
Research programme: rheumatoid arthritis diagnostics - Roche/Millenium Pharmaceuticals
Alternative Names: Rheumatoid arthritis diagnostics research programme - Roche/Millenium PharmaceuticalsLatest Information Update: 05 Nov 2003
Price :
$50
*
At a glance
- Originator Millennium Pharmaceuticals; Roche
- Developer Millennium Pharmaceuticals
- Class Diagnostic agents
- Mechanism of Action Diagnostic imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 05 Nov 2003 No development reported - Preclinical for Rheumatoid arthritis diagnosis in USA (unspecified route)
- 22 Jan 2001 Preclinical development for Rheumatoid arthritis diagnosis in USA (unspecified route)